Bottom line
PRHSX vs TRUH: the short answer
PRHSX (T. Rowe Price Health Sciences Fund, Inc.) and TRUH (VanEck Healthcare TruSector ETF) share a meaningful slice of their top holdings — about 80% by weight.
But PRHSX is far broader, holding 279 positions to 60 for TRUH, so beyond the top names it adds exposure TRUH doesn't have.
TRUH is cheaper at 0.1% vs 0.83% — a difference of $73 a year per $10,000 invested.
Updated Nov 19, 2026
PRHSX vs TRUH side by side
| PRHSX | TRUH | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | T. Rowe Price | VanEck |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.83% | 0.1% |
| Annual cost per $10k | $83 | $10 |
| 10-yr cost on $10k (prospectus) | $1,025 | — |
| Max front load | — | None |
| 12b-1 fee | — | — |
| 1-yr return | +17.7% | — |
| 5-yr return (annualized) | +4.2% | — |
| 10-yr return (annualized) | +9.1% | — |
| Best quarter | +23.5% | — |
| Worst quarter | −15.8% | — |
| Net assets (fund) | $11.9B | $833.1K |
| Number of holdings | 279 | 60 |
| Portfolio turnover | 62% | — |
| Returns as of | Dec 31, 2025 | — |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
17 of PRHSX's top 25 holdings also appear in TRUH's top 25.
| Holding | PRHSX | TRUH |
|---|---|---|
| Eli Lilly & Co | 14.28% | 16.56% |
| Johnson & Johnson | 6.63% | 10.67% |
| Unitedhealth Group Inc | 5.99% | 6.59% |
| Abbvie Inc | 5.10% | 7.76% |
| Merck & Co. Inc. | 4.01% | 5.54% |
| Gilead Sciences Inc | 2.82% | 2.74% |
| Thermo Fisher Scientific Inc | 2.52% | 3.25% |
| Vertex Pharmaceuticals Inc | 2.28% | 2.21% |
| Bristol-myers Squibb Co | 2.11% | 2.05% |
| Abbott Laboratories | 1.89% | 2.76% |
| Intuitive Surgical Inc | 1.87% | 2.48% |
| Amgen Inc | 1.82% | 3.39% |
| Stryker Corp | 1.78% | 1.89% |
| Elevance Health Inc | 1.53% | 1.49% |
| Danaher Corp | 1.43% | 2.10% |
Source: SEC Form N-PORT
PRHSX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
TRUH top 10
- Eli Lilly & Co — 16.56%
- Johnson & Johnson — 10.67%
- AbbVie Inc — 7.76%
- UnitedHealth Group Inc — 6.59%
- Merck & Co Inc — 5.54%
- Amgen Inc — 3.39%
- Thermo Fisher Scientific Inc — 3.25%
- Abbott Laboratories — 2.76%
- Gilead Sciences Inc — 2.74%
- Intuitive Surgical Inc — 2.48%
FAQ
What is the difference between PRHSX and TRUH?
Which is cheaper, PRHSX or TRUH?
Should I own both PRHSX and TRUH?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.